Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
18.47
-0.69 (-3.60%)
At close: Oct 31, 2025, 4:00 PM EDT
18.45
-0.02 (-0.11%)
After-hours: Oct 31, 2025, 7:58 PM EDT
Baxter International Revenue
Baxter International had revenue of $2.84B in the quarter ending September 30, 2025, with 5.04% growth. This brings the company's revenue in the last twelve months to $11.02B, up 3.90% year-over-year. In the year 2024, Baxter International had annual revenue of $10.64B with 2.66% growth.
Revenue (ttm)
$11.02B
Revenue Growth
+3.90%
P/S Ratio
0.86
Revenue / Employee
$290,079
Employees
38,000
Market Cap
9.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.64B | 276.00M | 2.66% |
| Dec 31, 2023 | 10.36B | 303.00M | 3.01% |
| Dec 31, 2022 | 10.06B | -2.09B | -17.20% |
| Dec 31, 2021 | 12.15B | 473.00M | 4.05% |
| Dec 31, 2020 | 11.67B | 311.00M | 2.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
BAX News
- 1 day ago - Baxter Trims Annual Outlook Again, Stock Hits 52-Week - Benzinga
- 1 day ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - GlobeNewsWire
- 1 day ago - Baxter International Inc. (BAX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Medical products maker Baxter cuts annual profit forecast on persistent hurricane impact - Reuters
- 2 days ago - Baxter Reports Third-Quarter 2025 Results - Business Wire
- 3 days ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - PRNewsWire
- 4 days ago - Artisan Partners Q3 2025 Position Updates - Seeking Alpha
- 4 days ago - BAXTER INTERNATIONAL INC. (NYSE: BAX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Baxter International Inc. Investors of Upcoming Deadline - GlobeNewsWire